Renalytix AI plc Cash Flow Conversion Efficiency

Latest as of December 2024: 4.746x

Renalytix AI plc cash flow conversion efficiency. Based on the latest financial reports, Renalytix AI plc (RENX) has a cash flow conversion efficiency ratio of 4.746x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-6.50 Million ≈ $-790.50 USD) by net assets (GBX-1.37 Million ≈ $-166.57 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Renalytix AI plc (2012–2025)

Cash flow conversion efficiency of Renalytix AI plc from 2012 to 2025. This chart illustrates how Renalytix AI plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View latest Renalytix AI plc stock price today for real-time trading data and today's change.

Renalytix AI plc Cash Flow Conversion Ratio Explained

Renalytix AI plc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Renalytix AI plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Renalytix AI plc ranked by their cash flow conversion efficiency. Also see Renalytix AI plc (RENX) total market value for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tongaat JSE:TON	1.602x
Itaconix plc LSE:ITX	-0.059x
TTA Holdings Ltd AU:TTA	-0.073x
Discovery-Corp Enterprises Inc. V:DCY	-0.574x
Multistack International Ltd AU:MSI	-0.834x
Elixxer Ltd V:ELXR	0.024x
M Winkworth PLC LSE:WINK	0.190x
Altair Resources Inc V:AVX	0.002x

Annual Cash Flow Conversion Efficiency for Renalytix AI plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Renalytix AI plc from 2012 to 2025. Review cash generation quality of Renalytix AI plc to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX-7.00 Million ≈ $-851.70	GBX-17.90 Million ≈ $-2.18K	2.557x	-33.30%
2024-06-30	GBX-7.85 Million ≈ $-955.60	GBX-30.11 Million ≈ $-3.66K	3.834x	+744.54%
2023-12-31	GBX20.76 Billion ≈ $2.53 Million	GBX9.43 Billion ≈ $1.15 Million	0.454x	+125.64%
2023-06-30	GBX18.45 Million ≈ $2.25K	GBX-32.67 Million ≈ $-3.98K	-1.771x	-67.09%
2022-06-30	GBX43.17 Million ≈ $5.25K	GBX-45.74 Million ≈ $-5.57K	-1.060x	-309.13%
2021-06-30	GBX95.10 Million ≈ $11.57K	GBX-24.63 Million ≈ $-3.00K	-0.259x	+7.42%
2020-06-30	GBX35.96 Million ≈ $4.38K	GBX-10.06 Million ≈ $-1.22K	-0.280x	-97.30%
2019-06-30	GBX28.17 Million ≈ $3.43K	GBX-3.99 Million ≈ $-485.95	-0.142x	-100.32%
2018-06-30	GBX-9.39K ≈ $-1.14	GBX-422.00K ≈ $-51.35	44.946x	+11298.75%
2016-12-31	GBX17.87 Billion ≈ $2.17 Million	GBX7.05 Billion ≈ $857.42K	0.394x	-6.04%
2015-12-31	GBX17.47 Billion ≈ $2.13 Million	GBX7.33 Billion ≈ $891.85K	0.420x	+30.71%
2014-12-31	GBX17.26 Billion ≈ $2.10 Million	GBX5.54 Billion ≈ $674.42K	0.321x	+4.07%
2013-12-31	GBX20.40 Billion ≈ $2.48 Million	GBX6.29 Billion ≈ $765.80K	0.308x	-28.02%
2012-12-31	GBX21.03 Billion ≈ $2.56 Million	GBX9.01 Billion ≈ $1.10 Million	0.429x	--

About Renalytix AI plc

LSE:RENX UK Health Information Services

Market Cap

$289.79K

GBX2.38 Billion GBX

Market Cap Rank

#31266 Global

#987 in UK

Share Price

GBX5.45

Change (1 day)

+0.00%

52-Week Range

GBX1.80 - GBX7.38

All Time High

GBX1220.00